Russell, Ronan
Carnese, Phichitpol P.
Hennings, Thomas G.
Walker, Emily M. http://orcid.org/0000-0001-8394-1567
Russ, Holger A. http://orcid.org/0000-0001-5117-2927
Liu, Jennifer S.
Giacometti, Simone
Stein, Roland
Hebrok, Matthias http://orcid.org/0000-0002-3833-8862
Funding for this research was provided by:
Juvenile Diabetes Research Foundation (3-PDF-2018-588-A-N)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK090570, R01 DK090570, R01 DK105831)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 23 July 2019
Accepted: 6 May 2020
First Online: 2 June 2020
Competing interests
: M.H. is affiliated with Semma Therapeutics (Consultant and SAB member, Stock holder) and Encellin Inc. (SAB member, Stock holder). He holds stocks from Viacyte Inc. (Stock holder) and receives research support from Eli Lilly. H.A.R. is a consultant and SAB Islet member to Sigilon therapeutics and SAB member at Prellis Biologics. All other authors declare no competing interests.